Hot Performing Companies For 2014

There are lots of nuclear energy companies that would like to leave 2012 behind. Of all the major energy sources, it was the only one that saw a global decline in total consumption. The decline in the United States was largely attributed to cheap natural gas, as it captured a much larger chunk of market share, while alternative energy options became more attractive. To compound the problem, the Fukushima Daiichi meltdown made several countries abroad rethink nuclear use. In Japan, 89% of all nuclear power was shut down as a result of the disaster.

So the question remains, where does nuclear go from here? The increasing attractiveness of solar and wind is going to make it harder and harder to justify using nuclear as a base-load power source, because the economics of doing so is not as attractive as that for natural gas or even coal. One element that could completely change the landscape is restrictions on carbon emissions. Tune in to the following video, where Fool.com contributor Tyler Crowe discusses what these events could mean for nuclear and what some utility companies are doing in light of these new trends. 

Hot Performing Companies For 2014: Pharma-Bio Serv Inc (PBSV.PK)

Pharma-Bio Serv, Inc.( Pharma-Bio), incorporated on June 8, 2006, is a compliance and technology transfer services consulting firm with a laboratory testing facility, servicing the Puerto Rico, United States and Europe markets. The Company is engaged in providing technical compliance consulting service, and microbiological and chemical laboratory testing services primarily to the pharmaceutical, chemical, medical device and biotechnology industries. The Company’s operating segments include Puerto Rico technical compliance consulting, United States technical compliance consulting, Ireland technical compliance consulting and a Puerto Rico microbiological and chemical laboratory testing division (Lab). These segments provide services primarily to the pharmaceutical, chemical, medical device and biotechnology industries in their respective markets. As on April 30, 2012, the Company acquired 100% interest in its subsidiary, Pharma-IR.

The Company provides a broa d range of compliance related consulting services. It also provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. It provides information technology consulting services and technical training/seminars. The Company offers services to its core industries already serviced as well as the cosmetic and food industries. The Company seeks opportunities in markets that could yield profitable margins using its professional consulting force and also provide services such as those performed by its microbiological testing laboratory facility, its information technology service division, Integratek, and its technical training division, Pharma Serv Academy.

The Company’s information technology services and consulting division based in Puerto Rico (Integratek) provides a variety of information technology services, such as Web pages and portals development, digital art design, intranets, extranets, software development including database integration, Window! s and Web applications development, software technical training and learning management systems, technology project management, and compliance consulting services, among others.

Advisors’ Opinion:

  • [By The Specialist]

    Normally when one of my stocks reports its earnings results after hours on a Friday, I cringe in anticipation of a bad report. Normally Friday after hours is a time slot reserved for companies who have disappointing results to deliver and wish to stay off radar. Naturally, when I got the alert on a Friday afternoon that Pharma-Bio Serv (PBSV.PK) had just reported its earnings results, I had one eye shut when opening the press release, fearing what would be inside.

Hot Performing Companies For 2014: Cannabis Science Inc (CBIS)

Cannabis Science, Inc., incorporated on May 4, 2007, is a development-stage company. The Company is engaged in the creation of cannabis-based medicines, both with and without psychoactive properties, to treats disease and the symptoms of disease, as well as for general health maintenance. On February 9, 2012, the Company acquired GGECO University, Inc. (GGECO). On March 21, 2012, the Company acquired Cannabis Consulting Inc. (CCI Group).

The Company is engaged in medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.

Advisors’ Opinion:

  • [By Bryan Murphy]

    Much like Nuvilex, Cannabis Science Inc. (OTCMKTS:CBIS) appears to simply be another conventional biotech outfit. And, truth be told, that’s what CBIS is. It just happens to be developing two drugs based on cannabinoids… one to reat HIV/AIDS, and the other to treat cancer. Both drugs are in preclinical trials right now, so an actual marketable product is still years down the road for Cannabis Science Inc. But, as a legitimate biotechnology that isn’t aiming to simply fuel tokers’ needs, it’s not going to hit any regulatory or law-enforcement roadblocks.

  • [By John Udovich]

    One almost has to feel sorry for old school small cap marijuana stocks like Medical Marijuana Inc (OTCMKTS: MJNA), Cannabis Science Inc (OTCMKTS: CBIS) and Hemp Inc (OTCMKTS: HEMP) which have been around awhile and increasingly have to contend with the marijuana newswires getting flooded with news from every small cap OTC stock along with your mother’s uncle’s fifth cousin trying to grab a piece of the marijuana hype. We alone had two specific articles (Small Cap Marijuana Stocks Aiming for a High With News: MCIG, FRTD & SKTO and Four Marijuana Small Caps Giving Investors Highs or Lows: ENRT, VMGI, NVLX & RTXBQ) covering about half a dozen different wannabe marijuana stocks with news for just this week along with another article (Putting My Call on Latteno Food in Perspective, Take-Two (LATF, MJNA, ERBB)) about another small cap that’s infusing food with weed. 

Hot Performing Companies For 2014: AT & S Austria Technologie & Systemtechnik AG (AUS)

AT & S Austria Technologie & Systemtechnik AG (AT&S) is an Austria-based company that is principally engaged in the production of printed circuit boards. The Company is divided into three core business units: Mobile Devices; Automotive, and Industrial. The Company’s product assortment ranges from single- and double-sided printed circuit boards to multilayer printed circuit boards. They are used as electromechanical linking elements, mainly in the telecommunication sector, automobile industry and medical technology applications, as well as defense and aerospace. AT&S operates production sites in Austria, India, China and Korea. It also maintains international sales offices, based in Austria, Ireland, Germany, the Czech Republic, France, Hungary and Belgium. As of March 31, 2011, the Company operated through its subsidiaries in India, Germany, Austria, China, Hong Kong, Japan, South Korea, Taiwan and the United States. Advisors’ Opinion:

  • [By Triska Hamid]

    Professors at the American University of Sharjah (AUS) are also looking at dental care with braces imbedded with a chip that monitor the movement of the fixtures and will communicate with the dentist’s office if any of them are separated from the teeth.

Hot Performing Companies For 2014: Stryker Corporation(SYK)

Stryker Corporation, together with its subsidiaries, operates as a medical technology company worldwide. The company operates in three segments: Reconstructive, MedSurg, and Neurotechnology and Spine. The Reconstructive segment offers orthopaedic reconstructive (hip and knee) and trauma implant systems, as well as other related products. The MedSurg segment provides surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; and other related products. The Neurotechnology and Spine segment offers neurovascular products, spinal implant systems, and other related products. The company sells its products through local dealers and direct sales force to doctors, hospitals, and other healthcare facilities, as well as through third-party dealers and distributors in the United States, Europe, the Middle East, Africa, and Japan, Canada, the Pacific region, and the Latin America region. Stryker Corporat ion was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Advisors’ Opinion:

  • [By Thomas Scarlett]

    Physicians today, and particularly surgeons, are using equipment and techniques that were undreamed of even a generation ago. A company that has been on the cutting edge of the medical technology revolution, with the prospect of more innovation ahead, is Stryker Corporation (NYSE: SYK).

    The Kalamazoo, Michigan-based firm has a diverse array of products that includes implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products.

    The company should be attractive to both growth- and income-oriented investors. Last month Stryker’s board of directors increased its dividend by 15 percent, compared to the prior year, by declaring a quarterly dividend of 30 cents per share.

    In the fourth quarter, Stryker posted net sales growth of 5.6 p ercent to $2.5 billion. Earnings per share increased 42 percent to $1.01 per share. For the full year, net sales growth was up 4.2 percent to $9 billion, and cash flow from operations increased 13.8 percent to $1.9 billion.

    The company has a market cap of $29.1 billion. Its debt levels seem quite reasonable considering its steady revenue growth, and its price-earnings ratio of 31 is justified by its history of innovation and expansion.

    In the United States, most of Stryker’s products are marketed directly to doctors, hospitals and other healthcare facilities. Internationally, Stryker products are sold in over 100 countries through company-owned sales subsidiaries and branches as well as third-party dealers and distributors.

    “We’re pleased with the organic sales growth and operational earnings we achieved in 2013. With our broad-based product portfolio and commitment to innovation and globalization, we’re well positioned to build on this momentum in 2014,&#82

  • [By Lauren Pollock]

    Stryker Corp.(SYK) agreed to acquire privately held surgical-equipment company Berchtold Holding AG for an enterprise value of $172 million. Berchtold, which has operations in Germany and the U.S., generated sales of roughly $125 million last year. The company’s products include surgical tables, equipment booms and surgical lighting systems.

  • [By Dividend Mantra]

    Stryker Corporation (SYK) increased its quarterly per share dividend by 15.1%, now paying out $0.3050. This represents an increase of $0.04 over the old dividend of $0.2650. Another very solid increase here, and SYK has increased its dividend for 21 consecutive years. The yield on the new payout is 1.47%. I’ve never taken a good look at Stryker because its yield is usually too low for me to consider it as a potential investment based on my income requirements, but the company continues to reward shareholders very well and I do quite like the business model of medical equipment. This is definitely a company I’d like to take a look at.

Hot Performing Companies For 2014: NeuroMetrix Inc.(NURO)

NeuroMetrix, Inc., a science-based health care company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders, such as those associated with diabetes, carpal tunnel syndrome, lumbosacral disc disease, and spinal stenosis. The company focuses on diagnosis and treatment of the neurological complications of diabetes, including diabetic peripheral neuropathy (DPN) and median neuropathy. Its marketed products include the ADVANCE NCS/EMG system, a platform for the performance of traditional nerve conduction studies and invasive electromyography procedures for the diagnosis and evaluation of CTS, low back and leg pain, and DPN; and the NC-stat DPNCheck, a device used to evaluate systemic neuropathies, such as DPN at the point-of-care, as well as consumables and accessories for use with its neurodiagnostic equipment. The company is also developing SENSUS pain therapy device, a transcutaneous electrical nerve stimul ator used in the management of chronic pain, such as that caused by DPN; and ADVANCE CTS, a version of the ADVANCE NCS/EMG device for the detection of CTS in people with diabetes. The company distributes its products directly through its direct sales force and independent sales representatives to physicians, clinics, and hospitals consisting of primary care, internal medicine, orthopedic and hand surgeons, pain medicine physicians, neurologists, physical medicine and rehabilitation, physicians, and neurosurgeons, as well as endocrinology/podiatry market in the United States and internationally. NeuroMetrix, Inc. was founded in 1996 and is headquartered in Waltham, Massachusetts.

Advisors’ Opinion:

  • [By Bryan Murphy]

    Don’t get me wrong – it’s fun to be right. There’s such a thing as being too right (or at least too right, too fast) though, and when that happens, the smart thing to do is, well do something about it. Case in point? I was right yesterday about Neurometrix Inc. (NASDAQ:NURO). I suggested the stock was already in the midst of a breakout, and NURO was poised to soar. I didn’t count on this morning’s big jump and subsequent gap, however, so now that my risk of continuing to hold it is as big as my potential reward from here, I and anybody else who followed my lead has a tough decision to make… though I’ve already made mine.

  • [By Bryan Murphy]

    My recent love affair with Neurometrix Inc. (NASDAQ:NURO) hasn’t exactly been a veiled secret. I first pointed out this diabetes-diagnostics stock was working on a technical breakout effort in early October, and I penned two more bullish-progress reports on NURO in November. Yet, the Neurometrix rally is still in its infancy, when you take a step back and look at the bigger weekly chart.

  • [By Bryan Murphy]

    If you missed the recent surges from Neurometrix Inc. (NASDAQ:NURO) and/or OXiGENE Inc. (NASDAQ:OXGN), and decided to skip an entry on either or both because they were too frothy at the time, then here’s some good news…. you’re getting a second chance. Both NURO and OXGN are getting their proverbial second wind, and they’re doing so at a price much lower than the price you would have had to pay for either just a few days ago. There’s just one catch – you may want to hurry of you want in. This second wind is unfurling as rapidly as the first surges did.

Hot Performing Companies For 2014: PMC – Sierra Inc.(PMCS)

PMC-Sierra, Inc. engages in the design, development, marketing, and support of semiconductor solutions for the enterprise infrastructure and communications infrastructure markets. Its products include controllers based on Fibre Channel, Serial Attached SCSI, and Serial ATA that enable the development of external and server-attached storage systems; framers and mappers, which convert the data into a format for transmission in the network before the data is sent to the next destination; line interface units that transmit and receive signals over a physical medium, such as wire, cable, or fiber; and microprocessor-based system-on-chips, which perform the high-speed computations that help in identifying and controlling the flow of signals and data in various network equipment used in the communications, storage, and enterprise markets. The company also offers packet and cell processors that examine the contents of cells or packets, and perform various management and reporting functions; radio frequency transceivers, which transmit and receive broadband signals over the air; and serializers/deserializers that convert and multiplex traffic between slower speed parallel streams and higher speed serial streams. PMC-Sierra sells its products to end customers directly, as well as through distributors and independent manufacturers? representatives primarily in China, Asia, Japan, Taiwan, Europe, the United States, and the Middle East. The company was founded in 1983 and is based in Santa Clara, California.

Advisors’ Opinion:

  • [By CRWE]

    PMC (Nasdaq:PMCS), the semiconductor innovator transforming networks that connect, move and store big data, reported that the Company will present at the Citi 2012 Technology Conference on September 5, 2012, in New York, NY.

Hot Performing Companies For 2014: Cott Corp (COT)

Cott Corporation (Cott), incorporated on December 31, 2006, is a producers of beverages on behalf of retailers, brand owners and distributors. The Company’s product lines include carbonated soft drinks (CSDs), 100% shelf stable juice and juice-based products, clear, still and sparkling flavored waters, energy products, sports products, new age beverages, and ready-to-drink teas, as well as alcoholic beverages for brand owners. The Company operates in five segments: North America (which includes the United States operating segment and Canada operating segment), the United Kingdom (which includes its United Kingdom reporting unit and its Continental European reporting unit), Mexico, Royal Crown International (RCI) and All Other. The Company markets or supplies over 500 retailer, licensed and Company-owned brands in its four core geographic segments. In March of 2012, its U.K. reporting segment acquired a beverage and wholesale business based in Scotland.

Advisors’ Opinion:

  • [By Rick Munarriz]

    It’s been a year of brand-widening initiatives for SodaStream, and not just because it cranked out its first Super Bowl ad back in February.

    In February it teamed up with Ocean Spray to co-develop cranberry juice blends exclusively for the SodaStream system. This follows deals last year with Crystal Light, Kool-Aid, and V8 for non-conventional carbonated beverages. My 2012 wish for SodaStream to strike a deal with Monster Beverage (NASDAQ: MNST  ) to make a bigger splash in the energy-drinks market hasn’t materialized, but a deal with EBOOST did happen earlier this year. The initial natural energy drink flavors of orange and acai pomegranate will hit the market as SodaStream syrups during the latter half of this year, packing an all-natural energy boost and vitamins in every serving. EBOOST doesn’t have the same allure as Monster or Red Bull, but the move was still a strong one since there’s a real value proposition for home-crafted energy drinks. If SodaStream is successful, the big boys will be on notice. In March, SodaStream, which is based in Israel, teamed up with private-label bottler Cott (NYSE: COT  ) to produce SodaStream’s existing flavors at its facility in Georgia, making it easier to get SodaStream products into the country with the world’s largest soda consumption per capita.

    The next chapter in what has been a successful year will naturally write itself on Wednesday. There is plenty to prove, even after SodaStream proves quarter after quarter that it’s not just a company behind a faddish novelty.

  • [By Dan Caplinger]

    But SodaStream is continuing to pull out all stops in order to improve its results. SodaStream’s recent partnership with Samsung to incorporate carbonation technology into high-end refrigerators could help drive growth for consumers who don’t want to deal with a separate appliance in their kitchens. Moreover, SodaStream’s deal in March with bottler Cott (NYSE: COT  ) to produce soda syrup within the U.S. should help it boost its efficiency in getting flavors to domestic customers.

Hot Performing Companies For 2014: AGCO Corporation (AGCO)

AGCO Corporation manufactures and distributes agricultural equipment and related replacement parts worldwide. The company provides tractors, including compact tractors for small farms and specialty agricultural industries comprising dairies, landscaping, and residential areas; utility tractors, such as two-wheel and all-wheel drive versions for small and medium-sized farms, and specialty agricultural industries consist of dairy, livestock, orchards, and vineyards; and horsepower tractors for large farms and on cattle ranches for hay production. It also offers application equipment, which includes self-propelled, three and four-wheeled vehicles, and related equipment for use in the application of liquid and dry fertilizers, and crop protection chemicals; chemical sprayer equipment for planting crops; and related equipment that comprises vehicles for waste application, as well as provides combines. In addition, the company offers hay tools and forage equipment consisting rou nd and rectangular balers, self-propelled windrowers, disc mowers, spreaders and mower conditioners for harvesting and packaging vegetative feeds; and engines, such as diesel engines, gears, and generating sets. Further, it provides implements, including disc harrows for improving field performance; heavy tillage to break up soil and mix crop residue; and field cultivators for preparing smooth seed bed and destroy weeds, as well as offers tractor-pulled planters and loaders. Additionally, the company provides precision farming technologies to enhance productivity and profitability on the farm; and other advanced technology precision farming products to gather information, such as yield data, as well as offers wholesale financing and retail financing. It markets its products under the Challenger, Fendt, Massey Ferguson, and Valtra brand names through a network of independent dealers and distributors. AGCO Corporation was founded in 1990 and is headquartered in Duluth, Georgi a .

Advisors’ Opinion:

  • [By Ben Levisohn]

    But don’t just buy any company, DeBlase says. Instead, focus on those that have EPS momentum, which has generated outperformance in 10 of the past 11 years, DeBlase says. As a result, investors should prefer Terex (TEX), her top pick, and Agco (AGCO), which she rates Outperform. John Deere (DE) and Parker Hannifin (PH) get tarred with Underweight ratings.

  • [By Mike the PhD]

    Historically the stock prices of Deere (DE) and other agricultural equipment firms and retailers like Case-New Holland (CNH), Titan Machinery (TITN), AGCO (AGCO), Tractor Supply (TSCO), Valmont (VAL), and Lindsay (LNN) have tended to closely track the price of corn. When corn prices go up, farmers tend to make more money, and they spend that money on new equipment from Deere and other firms. This relationship is especially strong for Deere and Corn, but it holds true for all of the stocks above to some extent. (Correlation coefficients between all of the stock prices above and corn are statistically significant to at least the 5% level, see my blog here for more details.)

  • [By Dan Caplinger]

    Kubota isn’t the only company aggressively challenging Deere. AGCO (NYSE: AGCO  ) has made aggressive expansion efforts in Africa, working with specialty agricultural lender Rabobank to try to help farmers on the continent buy more farming equipment. Moreover, both AGCO and CNH Global (NYSE: CNH  ) have made emerging markets like Latin America a high priority, reaping benefits from the more rapidly expanding economies among Latin American nations. Deere has targeted Latin America as well, but it hasn’t been as aggressive with its international efforts as its peers. Deere’s stock price has reflected its lack of initiative in expanding globally: